NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/26/2021
Back to search
Official data from USPTO
EVEREST CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EVEREST CLINICAL RESEARCH
ST13
US500000085216413Class
42
Filing
85216413
Registration
4098088
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
05/26/2021
Trademark type
Word
Nice classes
42
Filing date
01/12/2011
Registration date
02/14/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2021
Last transaction
05/26/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
10/21/2003
First use in commerce
10/21/2003
Drawing code
4
Owner type
03
Owner location
ONTARIO, CA
Examiner
STEEL, ALYSSA
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
E. C. (pessoa física)
Everest Clinical Research Services Inc.
Representatives
Camille M. Miller Cozen O'Connor
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biomedicalpharmaceuticalbiotechnology and health-related research study servicesconducting clinical trials in the field of clinical trials of drugsmedical devices and other interventions to determine efficacy and safetyparticularlyproviding the selection of trial subjects in accordance with research design criteriatrial management and site monitoringmonitoring trial participants for adverse reactions and preparation and presentation of reports of adverse reactionsadministration of clinical trial data and safety monitoring boardscollection and management of study dataclinical data management services and medical codinganalysis of study data including selection and application of statistical tests to study dataproviding biostatistics and statistical programmingdispensing drugs and managing drug inventoriesmonitoring design and conduct of trials for compliance with applicable regulations and policies and preparation and presentation of compliance reportsdevelopment and maintenance of Internet websites for reporting on studiesmedical writing and graphic design of research study protocolspreparation of reports of research studies and abstracts of reportspreparation and presentation of reports to study sponsors and regulatory authorities
Publications
History of USPTO decisions and trademark events.
30 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/26/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/26/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/26/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
02/18/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/14/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/31/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/17/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/17/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/14/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/13/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/13/2017
E815
TEAS SECTION 8 & 15 RECEIVED
02/14/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/14/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/14/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
02/14/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/29/2011
PUBO
PUBLISHED FOR OPPOSITION
11/29/2011
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/09/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/26/2011
ALIE
ASSIGNED TO LIE
10/26/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/29/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/23/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/05/2011
GNRT
NON-FINAL ACTION E-MAILED
04/05/2011
CNRT
NON-FINAL ACTION WRITTEN
04/05/2011
DOCK
ASSIGNED TO EXAMINER
03/31/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/18/2011
Continuous trademark protection
Get notified about every new filing that threatens EVEREST CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.